Evidence map›Paper›PMID 9874770›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Mechanisms by which IkappaB proteins control NF-kappaB activity.

S Simeonidis, D Stauber, G Chen, W A Hendrickson, D Thanos

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Barriers for HIV Cure: The Latent Reservoir.AIDS research and human retroviruses · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Regulation and function of nuclear IκBα in inflammation and cancer.American journal of clinical and experimental immunology · 2012
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S SimeonidisDepartment of Biochemistry and Molecular Biophysics, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
D Stauber
G Chen
W A Hendrickson
D Thanos

Funding

HIGH MOBILITY GROUP PROTEIN IN GENE TRANSCRIPTIONR01GM054605 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI THANOS, DIMITRIS · 1996 to 2002
$885k
NIGMS NIH HHS 1RO1GM54605NIGMS NIH HHS R01 GM054605
6 · The paper itself

Abstract

The biological activity of the transcription factor NF-kappaB is differentially controlled by three IkappaB proteins, Ikappa Balpha, Ikappa Bbeta, and Ikappa Bepsilon. We have examined the molecular basis for the differential inhibitory strengths of IkappaB proteins by constructing hybrid IkappaBs and found that the first ankyrin repeat of Ikappa Balpha is responsible for its strong inhibitory effect. Swapping a putative beta-turn within the first ankyrin repeat between the strong Ikappa Balpha and the weak IkappaBbeta inhibitors switches their in vivo inhibitory activity on NF-kappaB. The qualitatively distinct contacts made by this beta-turn in Ikappa Balpha and Ikappa Bbeta with NF-kappaB determine the efficiency by which IkappaBs sequester NF-kappaB to the cytoplasm, thus explaining their distinct effects on gene activity.

Indexed as

I-kappa B ProteinsAmino Acid SequenceAnkyrinsDNA-Binding ProteinsModels, MolecularMolecular Sequence DataNF-kappa BNF-KappaB Inhibitor alphaProtein BindingProtein Structure, SecondaryProto-Oncogene ProteinsRecombinant Fusion ProteinsRepetitive Sequences, Amino AcidAnkyrinsDNA-Binding ProteinsI kappa B beta proteinI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNFKBIE protein, humanProto-Oncogene ProteinsRecombinant Fusion Proteins

Identifiers

PMID9874770
PMCPMC15091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.